Prestige Consumer Healthcare, Inc. (PBH)
45.26
+0.49
(+1.09%)
USD |
NYSE |
Oct 02, 16:00
45.28
+0.02
(+0.04%)
Pre-Market: 20:00
Prestige Consumer Healthcare Max Drawdown (5Y) : 49.52% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 49.52% |
| August 31, 2026 | 49.00% |
| July 31, 2026 | 49.00% |
| June 30, 2026 | 49.00% |
| May 31, 2026 | 48.45% |
| April 30, 2026 | 41.09% |
| March 31, 2026 | 35.49% |
| February 28, 2026 | 35.49% |
| January 31, 2026 | 35.49% |
| December 31, 2025 | 37.57% |
| November 30, 2025 | 40.26% |
| October 31, 2025 | 42.94% |
| September 30, 2025 | 43.56% |
| August 31, 2025 | 43.56% |
| July 31, 2025 | 43.56% |
| June 30, 2025 | 43.56% |
| May 31, 2025 | 43.56% |
| April 30, 2025 | 43.56% |
| March 31, 2025 | 43.56% |
| February 28, 2025 | 49.07% |
| January 31, 2025 | 49.07% |
| December 31, 2024 | 49.07% |
| November 30, 2024 | 49.07% |
| October 31, 2024 | 49.07% |
| September 30, 2024 | 49.07% |
| Date | Value |
|---|---|
| August 31, 2024 | 49.07% |
| July 31, 2024 | 49.07% |
| June 30, 2024 | 49.07% |
| May 31, 2024 | 49.07% |
| April 30, 2024 | 49.90% |
| March 31, 2024 | 52.26% |
| February 29, 2024 | 53.75% |
| January 31, 2024 | 53.75% |
| December 31, 2023 | 53.75% |
| November 30, 2023 | 53.75% |
| October 31, 2023 | 53.75% |
| September 30, 2023 | 53.75% |
| August 31, 2023 | 53.75% |
| July 31, 2023 | 53.75% |
| June 30, 2023 | 53.75% |
| May 31, 2023 | 53.75% |
| April 30, 2023 | 53.75% |
| March 31, 2023 | 53.75% |
| February 28, 2023 | 53.75% |
| January 31, 2023 | 53.75% |
| December 31, 2022 | 53.75% |
| November 30, 2022 | 53.75% |
| October 31, 2022 | 53.75% |
| September 30, 2022 | 53.75% |
| August 31, 2022 | 53.75% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Supernus Pharmaceuticals, Inc. | 57.68% |
| Structure Therapeutics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -11.16 |
| Beta (5Y) | 0.3419 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 25.60% |
| Historical Sharpe Ratio (5Y) | -0.3022 |
| Historical Sortino (5Y) | -0.5067 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 12.35% |